Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer

BACKGROUND: Docetaxel (DCT) is widely used in clinical practice, but the drug resistance of breast cancer patients has become an important reason to limit its clinical efficacy. Chan’su is a commonly used traditional Chinese medicine for the treatment of breast cancer. Bufalin (BUF) is a bioactive p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Die, Jia, Tingting, Chen, Xingxing, Jiang, Haopeng, Guo, Teng, Dong, Junjun, Zeng, Hairong, Wang, Yixin, Yuan, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984844/
https://www.ncbi.nlm.nih.gov/pubmed/36879978
http://dx.doi.org/10.1016/j.heliyon.2023.e13840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984844/
https://www.ncbi.nlm.nih.gov/pubmed/36879978
http://dx.doi.org/10.1016/j.heliyon.2023.e13840

Ejemplares similares